IBDEI05F ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6927,2)
 ;;=^265141
 ;;^UTILITY(U,$J,358.3,6928,0)
 ;;=340.^^56^547^30
 ;;^UTILITY(U,$J,358.3,6928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6928,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,6928,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,6928,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,6929,0)
 ;;=729.2^^56^547^31
 ;;^UTILITY(U,$J,358.3,6929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6929,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,6929,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,6929,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,6930,0)
 ;;=053.19^^56^547^41
 ;;^UTILITY(U,$J,358.3,6930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6930,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,6930,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,6930,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,6931,0)
 ;;=310.9^^56^547^33
 ;;^UTILITY(U,$J,358.3,6931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6931,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,6931,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,6931,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,6932,0)
 ;;=332.0^^56^547^37
 ;;^UTILITY(U,$J,358.3,6932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6932,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,6932,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,6932,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,6933,0)
 ;;=250.60^^56^547^38
 ;;^UTILITY(U,$J,358.3,6933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6933,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,6933,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,6933,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,6934,0)
 ;;=356.9^^56^547^40
 ;;^UTILITY(U,$J,358.3,6934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6934,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,6934,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,6934,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,6935,0)
 ;;=780.2^^56^547^49
 ;;^UTILITY(U,$J,358.3,6935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6935,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,6935,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,6935,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,6936,0)
 ;;=724.3^^56^547^44
 ;;^UTILITY(U,$J,358.3,6936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6936,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,6936,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,6936,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,6937,0)
 ;;=780.39^^56^547^46
 ;;^UTILITY(U,$J,358.3,6937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6937,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,6937,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,6937,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,6938,0)
 ;;=782.0^^56^547^36
 ;;^UTILITY(U,$J,358.3,6938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6938,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,6938,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,6938,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,6939,0)
 ;;=435.9^^56^547^51
 ;;^UTILITY(U,$J,358.3,6939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6939,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,6939,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,6939,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,6940,0)
 ;;=354.2^^56^547^53
 ;;^UTILITY(U,$J,358.3,6940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6940,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,6940,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,6940,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,6941,0)
 ;;=729.1^^56^547^23
 ;;^UTILITY(U,$J,358.3,6941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6941,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,6941,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,6941,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,6942,0)
 ;;=438.20^^56^547^11
 ;;^UTILITY(U,$J,358.3,6942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6942,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,6942,1,5,0)
 ;;=5^CVA with Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,6942,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,6943,0)
 ;;=438.12^^56^547^10
 ;;^UTILITY(U,$J,358.3,6943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6943,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,6943,1,5,0)
 ;;=5^CVA with Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,6943,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,6944,0)
 ;;=356.8^^56^547^39
 ;;^UTILITY(U,$J,358.3,6944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6944,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,6944,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,6944,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,6945,0)
 ;;=337.20^^56^547^42
 ;;^UTILITY(U,$J,358.3,6945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6945,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,6945,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,6945,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,6946,0)
 ;;=294.8^^56^547^20
 ;;^UTILITY(U,$J,358.3,6946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6946,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,6946,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,6946,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,6947,0)
 ;;=438.6^^56^547^7
 ;;^UTILITY(U,$J,358.3,6947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6947,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,6947,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,6947,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,6948,0)
 ;;=438.7^^56^547^9
 ;;^UTILITY(U,$J,358.3,6948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6948,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,6948,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,6948,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,6949,0)
 ;;=438.84^^56^547^6
 ;;^UTILITY(U,$J,358.3,6949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6949,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,6949,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,6949,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,6950,0)
 ;;=434.91^^56^547^12
 ;;^UTILITY(U,$J,358.3,6950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6950,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,6950,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,6950,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,6951,0)
 ;;=333.94^^56^547^43
 ;;^UTILITY(U,$J,358.3,6951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6951,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,6951,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,6951,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,6952,0)
 ;;=345.90^^56^547^45
 ;;^UTILITY(U,$J,358.3,6952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6952,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,6952,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,6952,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,6953,0)
 ;;=344.1^^56^547^35
 ;;^UTILITY(U,$J,358.3,6953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6953,1,4,0)
 ;;=4^344.1
 ;;^UTILITY(U,$J,358.3,6953,1,5,0)
 ;;=5^Paraplegia NOS
 ;;^UTILITY(U,$J,358.3,6953,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,6954,0)
 ;;=437.9^^56^547^14
 ;;^UTILITY(U,$J,358.3,6954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6954,1,4,0)
 ;;=4^437.9
 ;;^UTILITY(U,$J,358.3,6954,1,5,0)
 ;;=5^Cerebrovascular Dis NOS
 ;;^UTILITY(U,$J,358.3,6954,2)
 ;;=^21803
 ;;^UTILITY(U,$J,358.3,6955,0)
 ;;=438.0^^56^547^4
 ;;^UTILITY(U,$J,358.3,6955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6955,1,4,0)
 ;;=4^438.0
 ;;^UTILITY(U,$J,358.3,6955,1,5,0)
 ;;=5^CVA Late Eff,Cog Deficit
 ;;^UTILITY(U,$J,358.3,6955,2)
 ;;=^317905
 ;;^UTILITY(U,$J,358.3,6956,0)
 ;;=438.10^^56^547^8
 ;;^UTILITY(U,$J,358.3,6956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6956,1,4,0)
 ;;=4^438.10
 ;;^UTILITY(U,$J,358.3,6956,1,5,0)
 ;;=5^CVA w/Speech/Language Deficit
 ;;^UTILITY(U,$J,358.3,6956,2)
 ;;=^317906
 ;;^UTILITY(U,$J,358.3,6957,0)
 ;;=438.11^^56^547^3
 ;;^UTILITY(U,$J,358.3,6957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6957,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,6957,1,5,0)
 ;;=5^CVA Late Eff w/Aphasia
 ;;^UTILITY(U,$J,358.3,6957,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,6958,0)
 ;;=438.9^^56^547^5
 ;;^UTILITY(U,$J,358.3,6958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6958,1,4,0)
 ;;=4^438.9
 ;;^UTILITY(U,$J,358.3,6958,1,5,0)
 ;;=5^CVA Late Eff,Unsp
 ;;^UTILITY(U,$J,358.3,6958,2)
 ;;=^269757
 ;;^UTILITY(U,$J,358.3,6959,0)
 ;;=780.50^^56^547^48
 ;;^UTILITY(U,$J,358.3,6959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6959,1,4,0)
 ;;=4^780.50
 ;;^UTILITY(U,$J,358.3,6959,1,5,0)
 ;;=5^Sleep Disturbance NOS
 ;;^UTILITY(U,$J,358.3,6959,2)
 ;;=^111287
 ;;^UTILITY(U,$J,358.3,6960,0)
 ;;=781.2^^56^547^24
 ;;^UTILITY(U,$J,358.3,6960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6960,1,4,0)
 ;;=4^781.2
 ;;^UTILITY(U,$J,358.3,6960,1,5,0)
 ;;=5^Gait Disturbance
 ;;^UTILITY(U,$J,358.3,6960,2)
 ;;=^48820
 ;;^UTILITY(U,$J,358.3,6961,0)
 ;;=781.99^^56^547^34
 ;;^UTILITY(U,$J,358.3,6961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6961,1,4,0)
 ;;=4^781.99
 ;;^UTILITY(U,$J,358.3,6961,1,5,0)
 ;;=5^Oth Sympt Nervous System
 ;;^UTILITY(U,$J,358.3,6961,2)
 ;;=^322159
 ;;^UTILITY(U,$J,358.3,6962,0)
 ;;=782.0^^56^547^32
 ;;^UTILITY(U,$J,358.3,6962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6962,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,6962,1,5,0)
 ;;=5^Numbness/Tingling
 ;;^UTILITY(U,$J,358.3,6962,2)
 ;;=^35757
 ;;^UTILITY(U,$J,358.3,6963,0)
 ;;=V12.59^^56^547^25
 ;;^UTILITY(U,$J,358.3,6963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6963,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,6963,1,5,0)
 ;;=5^HX CVA,No Residual
 ;;^UTILITY(U,$J,358.3,6963,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,6964,0)
 ;;=305.01^^56^548^15
 ;;^UTILITY(U,$J,358.3,6964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6964,1,4,0)
 ;;=4^305.01
 ;;^UTILITY(U,$J,358.3,6964,1,5,0)
 ;;=5^Etoh Abuse-Continuous
 ;;^UTILITY(U,$J,358.3,6964,2)
 ;;=^268228
 ;;^UTILITY(U,$J,358.3,6965,0)
 ;;=305.02^^56^548^2
